Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase-Reference-Cited by-同舟云学术

Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase

Published:1992-11 Issue:1 Volume:147 Page:58-62
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Hanger Diane P.,Hughes Kenneth,Woodgett James R.,Brion Jean-Pierre,Anderton Brian H.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference32 articles.

1. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule-binding region;Biernat;EMBO J.,1992

2. The distribution of tau in the mammalian central nervous system;Binder;J. Cell Biol.,1985

3. Isolated PHF and PHF-tau (A68) polypeptides in Alzheimer's disease contain epitopes from the whole sequence of different tau isoforms and modified sites recognized by RT97 and 8D8 anti-neurofilament antibodies;Brion;Neurobiol. Aging,1992

4. Tau in Alzheimer neurofibrillary tangles: N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site;Brion;Biochem. J.,1991

5. A68 proteins in Alzheimer's disease are composed of several tau isoforms in a phosphorylated state which affects their electrophoretic mobilities;Brion;Biochem. J.,1991

Cited by 666 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The pyrazolo[4,3-c]pyrazole core as a novel and versatile scaffold for developing dual DYRK1A-CLK1 inhibitors targeting key processes of Alzheimer's disease pathology;European Journal of Medicinal Chemistry Reports;2024-12

2. Disrupted mitochondrial response to nutrients is a presymptomatic event in the cortex of the APP^SAA knock‐in mouse model of Alzheimer's disease;Alzheimer's & Dementia;2024-08-22

3. Porphyromonas gingivalis LPS and Actinomyces naeslundii Conditioned Medium Enhance the Release of a Low Molecular Weight, Transcriptionally Active, Fragment of Glycogen Synthase-3 Kinase in IMR-32 Cell Line;Journal of Alzheimer's Disease Reports;2024-07-18

4. Capturing the Effects of Single Atom Substitutions on the Inhibition Efficiency of Glycogen Synthase Kinase-3β Inhibitors via Markov State Modeling and Experiments;Journal of Chemical Theory and Computation;2024-07-08

5. GSK3: A potential target and pending issues for treatment of Alzheimer's disease;CNS Neuroscience & Therapeutics;2024-07